A detailed history of Met Life Investment Management, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 42,052 shares of KURA stock, worth $375,944. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,052
Previous 42,052 -0.0%
Holding current value
$375,944
Previous $865,000 5.09%
% of portfolio
0.0%
Previous 0.01%

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$17.53 - $22.98 $82,741 - $108,465
4,720 Added 12.64%
42,052 $865,000
Q1 2024

May 14, 2024

BUY
$13.42 - $23.53 $500,995 - $878,421
37,332 New
37,332 $796,000
Q3 2023

May 09, 2024

BUY
$8.44 - $11.86 $12,119 - $17,030
1,436 Added 4.0%
37,332 $340,000
Q3 2023

Apr 29, 2024

BUY
$8.44 - $11.86 $12,119 - $17,030
1,436 Added 4.0%
37,332 $340,000
Q3 2023

Nov 14, 2023

BUY
$8.44 - $11.86 $12,119 - $17,030
1,436 Added 4.0%
37,332 $340,000
Q2 2023

Apr 29, 2024

BUY
$9.62 - $13.99 $345,319 - $502,185
35,896 New
35,896 $379,000
Q1 2023

May 09, 2024

BUY
$10.71 - $14.6 $384,446 - $524,081
35,896 New
35,896 $439 Million
Q4 2022

May 10, 2024

BUY
$11.23 - $16.9 $10,623 - $15,987
946 Added 2.71%
35,896 $445,000
Q4 2022

Mar 22, 2023

BUY
$11.23 - $16.9 $10,623 - $15,987
946 Added 2.71%
35,896 $445,000
Q4 2022

Feb 15, 2023

BUY
$11.23 - $16.9 $10,623 - $15,987
946 Added 2.71%
35,896 $445,000
Q3 2022

Jun 14, 2023

SELL
$12.01 - $19.45 $11,361 - $18,399
-946 Reduced 2.64%
34,950 $477,000
Q2 2022

Jun 20, 2023

SELL
$10.71 - $18.33 $10,131 - $17,340
-946 Reduced 2.64%
34,950 $640,000
Q1 2022

May 10, 2024

BUY
$11.78 - $16.98 $411,711 - $593,451
34,950 New
34,950 $561,000
Q1 2022

Jun 20, 2023

SELL
$11.78 - $16.98 $11,143 - $16,063
-946 Reduced 2.64%
34,950 $561,000
Q1 2022

Mar 22, 2023

BUY
$11.78 - $16.98 $132,254 - $190,634
11,227 Added 47.33%
34,950 $561,000
Q1 2022

May 12, 2022

BUY
$11.78 - $16.98 $132,254 - $190,634
11,227 Added 47.33%
34,950 $562,000
Q4 2021

Jun 21, 2023

SELL
$12.22 - $19.57 $148,754 - $238,225
-12,173 Reduced 33.91%
23,723 $332,000
Q3 2021

Jun 21, 2023

SELL
$15.42 - $21.72 $187,707 - $264,397
-12,173 Reduced 33.91%
23,723 $444,000
Q2 2021

Jun 21, 2023

SELL
$20.85 - $29.88 $253,807 - $363,729
-12,173 Reduced 33.91%
23,723 $494,000
Q1 2021

May 17, 2024

SELL
$24.75 - $39.14 $336,822 - $532,656
-13,609 Reduced 36.45%
23,723 $670,000
Q1 2021

Jun 26, 2023

SELL
$24.75 - $39.14 $301,281 - $476,451
-12,173 Reduced 33.91%
23,723 $671 Million
Q1 2021

Mar 22, 2023

SELL
$24.75 - $39.14 $87,021 - $137,616
-3,516 Reduced 12.91%
23,723 $670,000
Q1 2021

May 14, 2021

SELL
$24.75 - $39.14 $87,021 - $137,616
-3,516 Reduced 12.91%
23,723 $671,000
Q4 2020

May 24, 2024

BUY
$29.0 - $41.62 $90,799 - $130,312
3,131 Added 12.99%
27,239 $889,000
Q4 2020

Jun 22, 2023

SELL
$29.0 - $41.62 $251,053 - $360,304
-8,657 Reduced 24.12%
27,239 $889,000
Q4 2020

Mar 22, 2023

BUY
$29.0 - $41.62 $90,799 - $130,312
3,131 Added 12.99%
27,239 $889,000
Q4 2020

Feb 16, 2021

BUY
$29.0 - $41.62 $90,799 - $130,312
3,131 Added 12.99%
27,239 $890,000
Q3 2020

Jun 26, 2023

SELL
$16.3 - $30.64 $192,144 - $361,184
-11,788 Reduced 32.84%
24,108 $738,000
Q2 2020

May 24, 2024

SELL
$7.95 - $18.81 $105,130 - $248,743
-13,224 Reduced 35.42%
24,108 $393 Million
Q2 2020

Jun 26, 2023

SELL
$7.95 - $18.81 $93,714 - $221,732
-11,788 Reduced 32.84%
24,108 $392,000
Q2 2020

Mar 22, 2023

BUY
$7.95 - $18.81 $83,125 - $196,677
10,456 Added 76.59%
24,108 $392,000
Q2 2020

Aug 14, 2020

BUY
$7.95 - $18.81 $83,125 - $196,677
10,456 Added 76.59%
24,108 $393,000
Q1 2020

Jul 12, 2023

SELL
$6.45 - $14.04 $143,473 - $312,305
-22,244 Reduced 61.97%
13,652 $135,000
Q4 2019

Jul 12, 2023

SELL
$12.97 - $15.94 $288,504 - $354,569
-22,244 Reduced 61.97%
13,652 $187,000
Q3 2019

Jul 12, 2023

SELL
$14.75 - $20.87 $328,099 - $464,232
-22,244 Reduced 61.97%
13,652 $207,000
Q2 2019

Jul 12, 2023

SELL
$14.71 - $19.79 $327,209 - $440,208
-22,244 Reduced 61.97%
13,652 $268,000
Q1 2019

Jul 13, 2023

SELL
$13.73 - $16.87 $305,410 - $375,256
-22,244 Reduced 61.97%
13,652 $226,000
Q4 2018

Jul 13, 2023

SELL
$10.6 - $17.49 $235,786 - $389,047
-22,244 Reduced 61.97%
13,652 $191,000
Q4 2018

Mar 22, 2023

SELL
$10.6 - $17.49 $81,863 - $135,075
-7,723 Reduced 36.13%
13,652 $191,000
Q4 2018

Feb 14, 2019

SELL
$10.6 - $17.49 $81,863 - $135,075
-7,723 Reduced 36.13%
13,652 $192,000
Q3 2018

Jul 13, 2023

SELL
$16.65 - $21.85 $370,362 - $486,031
-22,244 Reduced 61.97%
13,652 $238,000
Q3 2018

Mar 22, 2023

SELL
$16.65 - $21.85 $241,774 - $317,283
-14,521 Reduced 40.45%
21,375 $374,000
Q3 2018

Nov 14, 2018

BUY
$16.65 - $21.85 $187,695 - $246,315
11,273 Added 111.59%
21,375 $374,000
Q4 2017

Feb 15, 2018

BUY
$13.5 - $16.65 $136,377 - $168,198
10,102
10,102 $155,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $598M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.